Yayın: Iloprost treatment in pediatric patients with complicated Raynaud's phenomenon
| dc.contributor.buuauthor | Çekiç, Şükrü | |
| dc.contributor.buuauthor | Kılıç, Sara Şebnem | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Çocuk İmmünolojisi ve Romatoloji Ana Bilim Dalı | |
| dc.contributor.orcid | 0000-0002-9574-1842 | |
| dc.contributor.orcid | 0000-0001-8571-2581 | |
| dc.contributor.researcherid | L-1933-2017 | |
| dc.contributor.researcherid | AAH-1658-2021 | |
| dc.contributor.scopusid | 56117061000 | |
| dc.contributor.scopusid | 34975059200 | |
| dc.date.accessioned | 2023-04-05T11:17:29Z | |
| dc.date.available | 2023-04-05T11:17:29Z | |
| dc.date.issued | 2015-11-25 | |
| dc.identifier.citation | Çekiç, Ş. ve Kılıç, S. Ş. (2016). "Iloprost treatment in pediatric patients with complicated Raynaud's phenomenon". Lupus, 25(5), 558-560. | |
| dc.identifier.doi | 10.1177/0961203315622898 | |
| dc.identifier.endpage | 560 | |
| dc.identifier.issn | 0961-2033 | |
| dc.identifier.issn | 1477-0962 | |
| dc.identifier.issue | 5 | |
| dc.identifier.pubmed | 26692039 | |
| dc.identifier.scopus | 2-s2.0-84962529394 | |
| dc.identifier.startpage | 558 | |
| dc.identifier.uri | https://doi.org/10.1177/0961203315622898 | |
| dc.identifier.uri | https://journals.sagepub.com/doi/10.1177/0961203315622898 | |
| dc.identifier.uri | http://hdl.handle.net/11452/32197 | |
| dc.identifier.volume | 25 | |
| dc.identifier.wos | 000372150400015 | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Sage Publications | |
| dc.relation.journal | Lupus | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Rheumatology | |
| dc.subject.emtree | C reactive protein | |
| dc.subject.emtree | D dimer | |
| dc.subject.emtree | Dipyridamole | |
| dc.subject.emtree | İloprost | |
| dc.subject.emtree | Myeloblastin | |
| dc.subject.emtree | Myeloperoxidase | |
| dc.subject.emtree | Nadroparin | |
| dc.subject.emtree | Neutrophil cytoplasmic antibody | |
| dc.subject.emtree | Nifedipine | |
| dc.subject.emtree | Vasodilator agent | |
| dc.subject.emtree | Adolescent | |
| dc.subject.emtree | Antiphospholipid syndrome | |
| dc.subject.emtree | Case report | |
| dc.subject.emtree | Child | |
| dc.subject.emtree | Childhood disease | |
| dc.subject.emtree | Cold exposure | |
| dc.subject.emtree | Cyanosis | |
| dc.subject.emtree | Disease course | |
| dc.subject.emtree | Doppler echography | |
| dc.subject.emtree | Ecchymosis | |
| dc.subject.emtree | Edema | |
| dc.subject.emtree | Erythrocyte sedimentation rate | |
| dc.subject.emtree | Female | |
| dc.subject.emtree | Follow up | |
| dc.subject.emtree | Foot pain | |
| dc.subject.emtree | Genetic variability | |
| dc.subject.emtree | Hepatitis A virus | |
| dc.subject.emtree | Hepatitis B virus | |
| dc.subject.emtree | Hepatitis C virus | |
| dc.subject.emtree | Hospital admission | |
| dc.subject.emtree | Human | |
| dc.subject.emtree | Hyperemia | |
| dc.subject.emtree | Immunofluorescence | |
| dc.subject.emtree | Immunoglobulin blood level | |
| dc.subject.emtree | Letter | |
| dc.subject.emtree | Medical history | |
| dc.subject.emtree | Partial thromboplastin time | |
| dc.subject.emtree | Physical examination | |
| dc.subject.emtree | Priority journal | |
| dc.subject.emtree | Protein electrophoresis | |
| dc.subject.emtree | Prothrombin time | |
| dc.subject.emtree | Raynaud phenomenon | |
| dc.subject.emtree | School child | |
| dc.subject.emtree | Treatment duration | |
| dc.subject.emtree | Antiphospholipid syndrome | |
| dc.subject.emtree | Blood flow | |
| dc.subject.emtree | Complication | |
| dc.subject.emtree | Drug effects | |
| dc.subject.emtree | Foot | |
| dc.subject.emtree | Foot ulcer | |
| dc.subject.emtree | Ischemia | |
| dc.subject.emtree | Onset age | |
| dc.subject.emtree | Pathophysiology | |
| dc.subject.emtree | Raynaud disease | |
| dc.subject.emtree | Treatment outcome | |
| dc.subject.emtree | Vascularization | |
| dc.subject.emtree | Vasoconstriction | |
| dc.subject.emtree | Wound healing | |
| dc.subject.mesh | Adolescent | |
| dc.subject.mesh | Age of onset | |
| dc.subject.mesh | Antiphospholipid syndrome | |
| dc.subject.mesh | Child | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Foot | |
| dc.subject.mesh | Foot ulcer | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Iloprost | |
| dc.subject.mesh | Ischemia | |
| dc.subject.mesh | Raynaud disease | |
| dc.subject.mesh | Regional blood flow | |
| dc.subject.mesh | Treatment outcome | |
| dc.subject.mesh | Vasoconstriction | |
| dc.subject.mesh | Vasodilator agents | |
| dc.subject.mesh | Wound healing | |
| dc.subject.wos | Rheumatology | |
| dc.title | Iloprost treatment in pediatric patients with complicated Raynaud's phenomenon | |
| dc.type | Letter | |
| dc.wos.quartile | Q3 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Çocuk İmmünolojisi ve Romatoloji Ana Bilim Dalı | |
| local.indexed.at | Scopus | |
| local.indexed.at | WOS |
Dosyalar
Lisanslı seri
1 - 1 / 1
